112 related articles for article (PubMed ID: 3021657)
1. The effect of formulation conditions on the distribution of 99mTc(NaBH4)-HEDP components separated by anion exchange HPLC.
Zodda JP; Tanabe S; Heineman WR; Deutsch E
Int J Rad Appl Instrum A; 1986; 37(4):345-54. PubMed ID: 3021657
[TBL] [Abstract][Full Text] [Related]
2. In vivo distributions of some component fractions of Tc(NaBH4)-HEDP mixtures separated by anion exchange high performance liquid chromatography.
Pinkerton TC; Ferguson DL; Deutsch E; Heineman WR; Libson K
Int J Appl Radiat Isot; 1982 Oct; 33(10):907-15. PubMed ID: 6818160
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m complexes of dimethylaminomethylene diphosphonate (DMAD)--II. Biological distributions of 99mTc-DMAD components isolated by anion exchange HPLC.
Holland ME; Bugaj J; Heineman WR; Deutsch E
Int J Rad Appl Instrum B; 1989; 16(3):313-7. PubMed ID: 2497091
[TBL] [Abstract][Full Text] [Related]
4. HPLC separated fractions of 99mTc(NaBH4)-HEDP as myocardial infarct imaging agents.
Ferguson DL; Libson K; Zodda JP; Heineman WR; Deutsch E
Int J Rad Appl Instrum A; 1986; 37(4):341-4. PubMed ID: 3021656
[TBL] [Abstract][Full Text] [Related]
5. Effect of pH on the formation of Tc(NaBH4)-MDP radiopharmaceutical analogues.
Tanabe S; Zodda JP; Deutsch E; Heineman WR
Int J Appl Radiat Isot; 1983 Dec; 34(12):1577-84. PubMed ID: 6230322
[TBL] [Abstract][Full Text] [Related]
6. The biological distributions of some technetium-MDP components isolated by anion exchange high performance liquid chromatography.
Tanabe S; Zodda JP; Libson K; Deutsch E; Heineman WR
Int J Appl Radiat Isot; 1983 Dec; 34(12):1585-92. PubMed ID: 6230323
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m complexes of dimethylaminomethylene diphosphonate (DMAD)--I. Anion exchange HPLC characterization of 99mTc(NaBH4)-DMAD mixtures.
Holland ME; Heineman WR; Deutsch E
Int J Rad Appl Instrum B; 1989; 16(3):301-11. PubMed ID: 2715016
[TBL] [Abstract][Full Text] [Related]
8. The effect of DMSO treatment on the performance of [99mTc]HEDP.
Bugaj JE; Esser PD; Tofe AJ; Borgia AT; Fawwaz RA
Int J Nucl Med Biol; 1984; 11(2):109-11. PubMed ID: 6434460
[TBL] [Abstract][Full Text] [Related]
9. Preparation and biological distribution of technetium diphosphonate radiotracers synthesized without stannous ion.
Deutsch E; Libson K; Becker CB; Francis MD; Tofe AJ; Ferguson DL; McCreary LD
J Nucl Med; 1980 Sep; 21(9):859-66. PubMed ID: 6774066
[TBL] [Abstract][Full Text] [Related]
10. Chromatographic characterization of electrochemically generated technetium-HEDP skeletal imaging agents.
Scott RB; Schofield PJ; Deutsch EA; Heineman WR
Talanta; 1989; 36(1-2):285-92. PubMed ID: 18964702
[TBL] [Abstract][Full Text] [Related]
11. The separation of 99mTc(Sn)EHDP complexes by HPLC and GPC.
de Groot GJ; Das HA; de Ligny CL
Int J Rad Appl Instrum A; 1986; 37(1):23-7. PubMed ID: 3019923
[TBL] [Abstract][Full Text] [Related]
12. Investigation of two new [99mTc]Tc-HEDP preparations that can be expected to give a better lesion-to-normal-bone uptake ratio when used as bone scanning agents.
de Ligny CL; Gelsema WJ; Hoevelaken TP; Schuring J
Nucl Med Biol; 1993 Jan; 20(1):23-9. PubMed ID: 8461877
[TBL] [Abstract][Full Text] [Related]
13. 99mTc bone scanning agents--I. Influence of experimental conditions on the formation and gel chromatography of 99mTc(Sn)pyrophosphate complexes.
Kroesbergen J; Gelsema WJ; De Ligny CL
Int J Nucl Med Biol; 1985; 12(2):83-8. PubMed ID: 2995268
[TBL] [Abstract][Full Text] [Related]
14. 186Re-HEDP: a potential therapeutic bone agent.
Weininger J; Ketring AR; Deutsch EA
Nuklearmedizin; 1984 Apr; 23(2):81-2. PubMed ID: 6433325
[TBL] [Abstract][Full Text] [Related]
15. Influence of complex charge and size on the uptake of 99mTc-diphosphonates in osteogenic tissue.
Pinkerton TC; Cheng KT; Shaw SM; Wilson GM
Int J Rad Appl Instrum B; 1986; 13(1):49-56. PubMed ID: 3095270
[TBL] [Abstract][Full Text] [Related]
16. In vitro stabilization of a low-tin bone-imaging agent (99mTc-Sn-HEDP) by ascorbic acid.
Tofe AJ; Francis MD
J Nucl Med; 1976 Sep; 17(9):820-5. PubMed ID: 822138
[TBL] [Abstract][Full Text] [Related]
17. Renal hyperconcentration of 99mTc-HEDP in experimental acute tubular necrosis.
Lavelle KJ; Park HM; Moseman AM; Lewis S
Radiology; 1979 May; 131(2):491-5. PubMed ID: 220670
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.
Subramanian G; McAfee JG; Blair RJ; Kallfelz FA; Thomas FD
J Nucl Med; 1975 Aug; 16(8):744-55. PubMed ID: 170385
[TBL] [Abstract][Full Text] [Related]
19. The effect of DMSO treatment on the composition of 99mTc(Sn)EHDP.
de Groot GJ; Das HA; de Ligny CL
Int J Rad Appl Instrum A; 1986; 37(6):487-90. PubMed ID: 3019948
[TBL] [Abstract][Full Text] [Related]
20. Skeletal uptake of Tc-99m HEDP in primary hyperparathyroidism.
Fogelman I; Greig WR; Bessent RG; Boyle IT
J Nucl Med; 1977 Oct; 18(10):1040-1. PubMed ID: 409748
[No Abstract] [Full Text] [Related]
[Next] [New Search]
